Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
Division | Study Number | Title | Investigator(s) | Release Date Sort ascending |
---|---|---|---|---|
DTMC | NIDA-CTO-0011 | Double-Blind, Placebo-Controlled, Dose Response Trial Of Ondansetron For The Treatment Of Methamphetamine Dependence | Bankole Johnson, DSc., M.D., Ph.D. | Jan 15, 2019 |
DTMC | NIDA-CTO-0012 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Jan 15, 2019 |
CTN | NIDA-CTN-0049 | Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users | Lisa Metsch, Ph.D., Carlos del Rio, M.D. | Sep 07, 2018 |
CTN | NIDA-CTN-0053 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) | Kevin M. Gray, MD | Jul 13, 2018 |
DTMC | NIDA-CSP-1019 | Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence | Ahmed Elkashef, M.D., Paul J. Fudala, Ph.D. | May 07, 2018 |
DTMC | NIDA-CSP-1022 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation | Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH | May 07, 2018 |
DTMC | NIDA-CTO-0008 | Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence | Richard Rawson, Ph.D. | May 07, 2018 |
DTMC | NIDA-CTO-0010 | Assessment of Potential Interactions Between Methamphetamine and Bupropion | Thomas F. Newton, M.D. | May 07, 2018 |
DTMC | NIDA-MDS-0002 | Assessment of Interactions Between Methamphetamine and Aripiprazole | Thomas F. Newton, M.D. | May 07, 2018 |
DTMC | NIDA-CSP-1021 | Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence | Liza Gorgon, M.A. | May 07, 2018 |